MSB 3.95% 92.0¢ mesoblast limited

Sepsis... quickest way to prove Stem cell efficacy, page-3

  1. 193 Posts.
    lightbulb Created with Sketch. 137
    Hi Dronil, MSB does not have a Sepsis trial going so it was off topic. What I was alluding to was if a cell therapy company had a Sepsis trial running it could be completed quickly.
    Problem is that FDA has been delaying approval of cell therapy trials...
    That being said many trials are just now coming to an end. Some investors thought because of the safety and efficacy shown in numerous cell therapy trials that some indications would have been approved before the end of phase 3 trials... Common sense says yes.
    But here we are waiting for regulatory approval for therapies that have shown safety and efficacy for some time....
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
92.0¢
Change
0.035(3.95%)
Mkt cap ! $1.067B
Open High Low Value Volume
88.5¢ 95.0¢ 88.0¢ $4.177M 4.538M

Buyers (Bids)

No. Vol. Price($)
7 60665 91.5¢
 

Sellers (Offers)

Price($) Vol. No.
92.0¢ 52225 19
View Market Depth
Last trade - 14.49pm 06/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.